Clossacillina [DCIT] en es it fr

Clossacillina [DCIT] Brand names, Clossacillina [DCIT] Analogs

Clossacillina [DCIT] Brand Names Mixture

  • No information avaliable

Clossacillina [DCIT] Chemical_Formula


Clossacillina [DCIT] RX_link

No information avaliable

Clossacillina [DCIT] fda sheet

Clossacillina [DCIT] msds (material safety sheet)

Clossacillina_[DCIT] MSDS

Clossacillina [DCIT] Synthesis Reference

No information avaliable

Clossacillina [DCIT] Molecular Weight

435.882 g/mol

Clossacillina [DCIT] Melting Point

No information avaliable

Clossacillina [DCIT] H2O Solubility

13.9 mg/L

Clossacillina [DCIT] State


Clossacillina [DCIT] LogP


Clossacillina [DCIT] Dosage Forms

Capsules (250 mg, 500 mg); Powder (125 mg/5 mL when reconstituted)

Clossacillina [DCIT] Indication

Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci.

Clossacillina [DCIT] Pharmacology

Cloxacillin is a semisynthetic antibiotic in the same class as penicillin. Cloxacillin is for use against staphylococci that produce beta-lactamase.

Clossacillina [DCIT] Absorption

Well absorbed from the gastrointestinal tract.

Clossacillina [DCIT] side effects and Toxicity

Oral LD50 in rat and mouse is 5000 mg/kg. Intravenous LD50 in rat is 1660 mg/kg. Symptoms of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, and swelling of face, lips, tongue, or throat.

Clossacillina [DCIT] Patient Information

Clossacillina [DCIT] Organisms Affected

Enteric bacteria and other eubacteria